Join us for our fourth episode of AustinPx Live where Chief Scientific Officer, Dave Miller, Ph.D., will share how AustinPx uses enabling formulation strategies to advance molecules once considered too complex to develop. He’ll highlight how our expertise with KinetiSol™, polymer and excipient screening, and biopharm-guided design-of-experiments creates formulations that achieve exposure, maintain stability, and are built for real-world manufacturability. This 30-minute session includes a 20-minute presentation followed by live Q&A.